Navigation Links
New research network for multiple sclerosis research
Date:1/14/2013

To date, Multiple Sclerosis (MS) has been considered to be an incurable disease involving the immune system and its exact causes are still unknown. Why exactly is there inadequate communication between the various kinds of immune cells in patients with the autoimmune disease MS? Why are the brains of MS patients the targets of "accidental" attacks by their own immune system? It is hoped that the research network ITN-NeuroKine, currently in the process of being formed under the aegis of the University Medical Center of Johannes Gutenberg University Mainz (JGU) with the help of EUR 3.5 million in funding provided by the European Commission, will provide answers to these questions. ITN stands for Initial Training Network, a concept established as one of the Marie Curie Actions and designed to promote European networks for the structured training of young researchers. 'NeuroKine' is an acronym for 'Neurological disorders orchestrated by cytoKines'. The ITN NeuroKine network was launched on January 1, 2013.

"The core objective of our new ITN-NeuroKine research network is to gain insight into the impairment of communication between immune cells," explained Professor Dr. Ari Waisman, Director of the Institute of Molecular Medicine (IMM) at the Mainz University Medical Center. "We will specifically be focusing on the soluble proteins called cytokines, which regulate the communication between these cells." Immune cells are mobile and are present at various sites in the body.

The ITN-NeuroKine research network is composed of an international team of researchers with a broad range of expertise in the areas of molecular and cellular neuroimmunology and neuropathology. The participants are scientists from the University of Zrich (UZH), the Medical University of Vienna (MUW), the Parisian Institut National de la Sant et de la Recherche Mdicale (INSERM), the Universit Vita-Salute San Raffaele (USR) in Milan, the Weizmann Institute of Science (WIS) based in Rehovot, Israel, the Erasmus University Medical Center in Rotterdam (EMC), and the Charit University Hospital in Berlin together with various commercial medical organizations, such as Miltenyi Biotech GmbH, Apitope Technology Ltd., Phenex Pharmaceuticals AG, and the Mainz-based BioNTech AG. Also participating are the Postdoc Career Development Initiative (PCDI) in Utrecht, the Novartis Institutes for BioMedical Research in Basel, and GlaxoSmithKline.

"The creation of the ITN-NeuroKine research network is crucial to the reputation of Mainz as a science hub. On the one hand, the ITN-NeuroKine network will be conducting cutting-edge research into the area where brain and immune system interact. At the same time, this network will be providing young researchers with the opportunity to receive specialized training," emphasized Professor Dr. Dr. Reinhard Urban, Chief Scientific Officer of the Mainz University Medical Center.


'/>"/>
Contact: Dr. Rene Dillinger-Reiter
pr@unimedizin-mainz.de
49-613-117-7424
Johannes Gutenberg Universitaet Mainz
Source:Eurekalert

Related biology news :

1. Study by UC Santa Barbara researchers suggests that bacteria communicate by touch
2. Research reveals first evidence of hunting by prehistoric Ohioans
3. Diabetes Research Institute develops oxygen-generating biomaterial
4. APS issues new policy requiring identification of sex or gender in reporting scientific research
5. UC Santa Barbara researchers discover genetic link between visual pathways of hydras and humans
6. Study jointly led by UCSB researcher supports theory of extraterrestrial impact
7. U of Alberta researcher steps closer to understand autoimmune diseases
8. Research on flavanols and procyanidins provides new insights into how these phytonutrients may positively impact human health
9. A project to research biological and chemical aspects of microalgae to fuel approach
10. Scripps Research discoveries lead to newly approved drug for infant respiratory distress syndrome
11. Researchers attempt to solve problems of antibiotic resistance and bee deaths in one
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/29/2016)... March 29, 2016 LegacyXChange, Inc. ... "LEGX" and SelectaDNA/CSI Protect are pleased to announce our ... in a variety of writing instruments, ensuring athletes signatures ... created collectibles from athletes on LegacyXChange will be assured ... the DNA. Bill Bollander , CEO ...
(Date:3/22/2016)... Ontario , PROVO and ... Newborn Screening Ontario (NSO), which operates the ... for molecular testing, and Tute Genomics and UNIConnect, ... management technology respectively, today announced the launch of a ... next-generation sequencing (NGS) testing panel. NSO ...
(Date:3/17/2016)... ABI Research, the leader in transformative ... market will reach more than $30 billion by ... Consumer electronics, particularly smartphones, continue to boost the ... reach two billion shipments by 2021 at a ... Research Analyst at ABI Research. "Surveillance is also ...
Breaking Biology News(10 mins):
(Date:5/2/2016)... , May 2, 2016 Q ... its technology partner Mannin Research Inc. will be attending ... which takes place from May 1-5, 2016 in ... be meeting with its vendors and research partners. The ... development goals and other collaborative opportunities for the MAN-01 ...
(Date:4/29/2016)... Italy (PRWEB) , ... April 30, 2016 , ... The ... extraordinary textile design, the bioLogic team explored how bacterial properties can be applied to ... of using Natto bacteria, which move in response to humidity change. The team harvested ...
(Date:4/29/2016)... ... April 29, 2016 , ... ... to transform technology into a viable company, CereScan’s CEO, John Kelley, joined other ... a recognized leader and mentor in the Denver area business community, shared his ...
(Date:4/28/2016)... 28, 2016 The report "Cryocooler ... Cryocoolers), Service (Technical Support, Product Repairs & Refurbishment, Preventive ... Forecast to 2022", published by MarketsandMarkets, the global market ... 2022, at a CAGR of 7.29% between 2016 and ... and 94 Figures spread through 159 Pages and in-depth ...
Breaking Biology Technology: